Management patterns and costs of acute ischemic stroke: An International study

Stroke

Volumn 31, Issue 3, 2000, Pages 582-590

  Caro, J Jaime ^a,b   Huybrechts, Krista F ^a   Duchesne, Inge ^c  

^a CARO RESEARCH INSTITUTE   (United States)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Clinical trials; Costs and cost analysis; Stroke management

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COMMUNITY CARE; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESOURCE ALLOCATION;

EID: 0034111565     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.3.582     Document Type: Article

References (25)

1. Holloway RG, Benesch CG, Rahilly CR, Courtright CE. A systematic review of cost-effectiveness research of stroke evaluation and treatment. Stroke. 1999;30:1340-1349.
2. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne M-H, Hennerici M, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
3. Samsa GP, Reutter RA, Parmigiani G, Ancukiewicz M, Abrahamse P, Lipscomb J, Matchar DB. Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to acute ischemic stroke. J Clin Epidemiol. 1999;52:259-271.
4. Caro JJ, Huybrechts KF, for the Stroke Economic Analysis Group. Stroke treatment economic model (STEM): predicting long-term costs from functional status. Stroke. 1999;30:2574-2579.
5. Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, Marier JR, Levine SR, Broderick JP, Kwiatkowski TG, Frankel M, Brott TG, Walker MD, NINDS rt-PA Stroke Study Group. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology. 1998;50: 883-890.
6. Grotta J, for the US and Canadian Lubeluzole Ischemic Stroke Study Group. Lubeluzole treatment of acute ischemic stroke. Stroke. 1997;28: 2338-2346.
7. Diener HC, for the European and Australian Lubeluzole Ischemic Stroke Study Group. Multinational randomized trial of lubeluzole in acute ischemic stroke. Cerebrovasc Dis. 1998;8:172-181.
8. Netten A, Dennett J. Unit Costs of Health and Social Care. Canterbury, UK: Personal Social Services Research Unit, University of Kent; 1996.
9. National Health Service. Scottish Health Service Costs. Edinburgh, Scotland: Information and Statistics Division, National Health Service; 1995.
10. Caro J, Klittich W, McGuire A, Ford I, Pettitt D, Nome J, Shepherd J, for the WOSCOPS Economic Analysis Committee. International economic analysis of primary prevention of cardiovascular disease with pravastatin in WOSCOPS. Eur Heart J. 1999;20:263-268.
11. Adams HP Jr, Bendixen BH, Rappelle LJ, Biller J, Love BB, Gordon DL, Marsh E, and the TOAST Investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993;24:35-41.
12. Rutten-Van Mölken MPMH, Van Doorslaer EKA, Van Vliet RCJA. Statistical analysis of cost outcomes in a randomized controlled clinical trial. Health Econ. 1994;3:333-345.
13. Arboix A, Vericat MC, Pujades R, Massons J, Garcia-Eroles L, Oliveres M. Cardioembolic infarction in the Sagrat Cor-Alianza Hospital of Barcelona Stroke Registry. Acta Neurol Scand. 1997;96:407-412.
14. Brainin M, Seiser A, Czvitkovits B, Pauly E. Stroke subtype is an age-independent predictor of first-year survival. Neuroepidemiology. 1992;11:190-195.
15. Kalra L. The influence of stroke unit rehabilitation on functional recovery from stroke. Stroke. 1994;25:821-825.
16. Strand T, Asplund K, Eriksson S, Hägg E, Lithner F, Wester PO. Stroke unit care: who benefits? comparisons with general medical care in relation to prognostic indicators on admission. Stroke. 1986;17:377-381.
17. Stroke Units Trialists' Collaboration. Collaborative systematic review of the randomized trials of organized inpatient (stroke unit) care after stroke. BMJ. 1997;314:1151-1159.
18. Jørgenson HS, Nakayama H, Raaschou HO, Olsen TS. Acute stroke care and rehabilitation: an analysis of the direct cost and its clinical and social determinants: the Copenhagen Stroke Study. Stroke. 1997;28:1138-1141.
19. Diringer MN, Edwards DF, Mattson DT, Akins PT, Sheedy CW, Hsu CY, Dromerick AW. Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Stroke. 1999;30:724-728.
20. Alexander MP. Stroke rehabilitation outcome: a potential use of predictive variables to establish levels of care. Stroke. 1994;25:128-134.
21. Drummond M, Davies L. Economic analysis alongside clinical trials: revisiting the methodological issues. Int J Technol Assess Health Care. 1991;7:561-573.
22. Beech R, Ratcliffe M, Tilling K, Wolfe C. on behalf of the participants of the European Study of Stroke Care. Hospital services for stroke care: a European perspective. Stroke. 1996;27:1958-1964.
23. Aho K, Harmsen P, Hatono S, Marquardsen J. Smirnov VE, Strasser T, on behalf of the participants in the WHO Collaborative Study on the Control of Stroke in the Community. Cerebrovascular disease in the community: a result of a WHO collaborative study. Bull World Health Organ. 1980;58:113-130.
24. Persson U, Silverberg R, Lindgren B, Norrving B, Jadbäck G, Johansson B, Puranen B-I. Direct costs of stroke for a Swedish population. Int J Technol Assess Health Care. 1990;6:125-137.
25. Dennis M, Langhorne P. So stroke units save lives: where do we go from here? BMJ. 1994;309:1273-1277.